Jinming Gao is a Professor of Oncology, Pharmacology and Otolaryngology at UT Southwestern Medical Center. He holds a Robert B. and Virginia Payne Professorship in Oncology and Mendelson-Young Endowment in Cancer Therapeutics. Faculty Profile
Dr. Gao received his B.S. in chemistry from Peking University and graduated with a PhD in physical organic chemistry from Harvard University. He then went on and completed postdoctoral training in biomedical engineering at Massachusetts Institute of Technology. Dr. Gao started his faculty career in the Department of Biomedical Engineering at Case Western Reserve University. He moved his lab to UT Southwestern Medical Center in 2005. Dr. Gao has written more than 120 articles and has 14 issued or pending patents worldwide. He has served as the past Chair of Gene and Drug Delivery study section, and is a member of the Advisory Council to the Center for Scientific Review at the National Institutes of Health.
A noteworthy achievement of Dr. Gao’s Group is the invention of proton transistor technology to digitize acidotic signals in biology and medicine. Together with Dr. Baran Sumer, a long-time collaborator and a head/neck cancer surgeon, Dr. Gao founded OncoNano Medicine to help translate proton transistor technology to patient care. A fluorescent nanoparticle sensor, ONM-100, has successfully completed Phase I clinical trial in 30 cancer patients and received a fast-track status from the FDA to start the Phase 2 trial in pan-cancer surgery. In recent years, the research team has moved into the field of immuno-oncology. Another lab invention, STING nanoparticle vaccine (ONM-500), has received $15.4 million from CPRIT for T cell immunotherapy of HPV-induced cancers. As part of the Cancer Moonshot Initiative from the National Cancer Institute, Dr. Gao and team have recently received a U54 Nano-Immune-Engineering Center Award to develop innovative nanotherapeutics to advance cancer immunotherapy.